[Plasmapheresis in combined measures to prevent postoperative thromboembolic complications in cancer patients].
Plasmapheresis with exfusion of 30-60% circulating plasma volume has been first used in combination with conventional drug therapy for the prevention of postoperative thromboembolic complications in cancer patients at risk of thrombosis (II-III stage lung cancer). The use of plasmapheresis made it possible to reduce the incidence of postoperative thromboembolic complications by 40.6% and to decrease postoperative lethality.
Tarabykin
A A
AA
Kliachkin
B M
BM
Basargin
S T
ST
D001780:Blood Coagulation Tests; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000150:complications* / Q000601:surgery; D008875:Middle Aged; D010956:Plasmapheresis; D011182:Postoperative Care / Q000379:methods; D011183:Postoperative Complications / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*
Plazmaferez v komplekse meropriiatiĭ po profilaktike posleoperatsionnykh tromboémbolicheskikh oslozhneniĭ u onkologicheskikh bol'nykh.